Advertisement

Journal of General Internal Medicine

, Volume 10, Issue 12, pp 656–662 | Cite as

Community patterns of transdermal nicotine use and provider counseling

  • Susan H. Swartz
  • Allan J. Ellsworth
  • Susan J. Curry
  • Edward J. Boyko
Original Articles

Abstract

OBJECTIVES: To examine bow transdermal nicotine is prescribed and used in the general population, and to identity variables associated with successful smoking cessation in patch users.

DESIGN: Retrospective cohort survey.

SETTING: A random sample of 70 pharmacies in King County, Washington, were asked to participate. Of those, 33 pharmacies ran computer searches of prescriptions for any nicotine patch dispensed between July 1 and December 31,1992. A total of 1,087 individuals receiving patches were identified.

PATIENTS: At least eight months after the nicotine patches were purchased, 972 subjects received questionnaires by mail from the participating pharmacies. The survey was completed by 433 (45.2%) subjects.

MAIN RESULTS: Eighty percent of the respondents requested patches from a provider, 81% of whom were primary care physicians. Ninety-six percent used the patch, 45% smoked while using the patch, and 37% reported having quit smoking. Smoking cessation was associated with daily patch application (odds ratio [OR] 1.6,95% confidence interval [CI] 1.2–2.2), abstinence during patch use (OR 7.7, 95% CI 4.8–12.5), and a longer duration of patch use (p=0.001). A score reflecting counseling intensity by the provider was associated with abstinence while using patches and smoking cessation (x2 for trend=0.01 and 0.04, respectively).

CONCLUSIONS: Most nicotine patch users request treatment from a primary care physician, suggesting motivation to quit. Almost half continue to smoke while using the patch, a behavior that appears related to a lower level of counseling and an inability to quit. Increasing counseling may positively impact nicotine-patch-assisted smoking cessation in the general population.

Key words

smoking smoking cessation nicotine transdermal transcutaneous administration pharmacy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hughes JR. Miller SA. Nicotine gum to help stop smoking. JAMA. 1984;252:2855–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Schneider NG, Jarvik ME. Time course of smoking withdrawal symptoms as a function of nicotine replacement. Psychopharmacology. 1984;82:143–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Hughes JR. Hatsukami DK. Pickens RW, et al. Effect of nicotine gum on the tobacco withdrawal syndrome. Psychopharmaeology. 1984;83:82–7.CrossRefGoogle Scholar
  4. 4.
    Daughton DM, Heatley SA. Prendergast JJ. et al. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy: a randomized, placebo-controlled, double-blind study. Arch Intern Med. 1991;151:749–52.PubMedCrossRefGoogle Scholar
  5. 5.
    Tonnesen P. Norregaard J, Simonsen K, Sawe U. A double-blind trial of 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med. 1991;325:311–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Abelin T. Muller P, Buehler A, Vesanen K. Imhof PR. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet. 1989;1:7–10.PubMedCrossRefGoogle Scholar
  7. 7.
    Rose JE, Levin ED, Behm FM, Adivi C. Schur C. Transdermal nicotine facilitates smoking cessation. Clin Pharmacol Ther. 1990;47:323–30.PubMedCrossRefGoogle Scholar
  8. 8.
    Hurt RD, Lauger GG, Offord KP, Kottke TE, Date LC. Nicotine-replacement therapy with use of a transdermal nicotine patch: a randomized double-blind placebo-controlled trial. Mayo Clin Proc. 1990;65:1529–37.PubMedGoogle Scholar
  9. 9.
    Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six-month results from two multi-center controlled clinical trials. JAMA 1991;266:3133–3138.CrossRefGoogle Scholar
  10. 10.
    Buchkremer G, Bents H, Horstmann M, Opitz K, Tolle R. Combination of behavioral smoking cessation with transdermal nicotine substitution. Addict Behav. 1989;14:229–38.PubMedCrossRefGoogle Scholar
  11. 11.
    Fiore MC, Kenford SL. Jorenby DE, Wetter SW, Smith SS, Baker TB. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest. 1994;105:524–33.PubMedGoogle Scholar
  12. 12.
    Sachs DPL, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med. 1993;153:1881–90.PubMedCrossRefGoogle Scholar
  13. 13.
    Westman EC. Levin ED, Rose JE. The nicotine patch in smoking cessation: a randomized trial with telephone counseling. Arch Intern Med. 1993;153:1917–23.PubMedCrossRefGoogle Scholar
  14. 14.
    Lam W, Sze PC, Sacks HS, Chalmers TC. Meta-analysis of randomised controlled trials of nicotine chewing gum. Lancet. 1987;2:27–30.PubMedCrossRefGoogle Scholar
  15. 15.
    Johnson RE, Hollis JF, Stevens VJ, Woodson GT. Patterns of nicotine gum use in a health maintenance organization. Drug Intell Clin Pharm. 1991;25:730–5.Google Scholar
  16. 16.
    Cummings SR, Hansen B, Richard RJ, Stein MJ, Coates TJ. Internists and nicotine gum. JAMA. 1988;260:1565–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Prochazka AV, Boyko EJ. How physicians can help their patients quit smoking: a practical guide. West J Med. 1988;149:188–94.PubMedGoogle Scholar
  18. 18.
    Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA. 1994;271:1940–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Anda RF, Remington PL, Sienko DG, Davis RM. Are physicians advising smokers to quit? JAMA. 1987;257:1916–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Orleans CT, Resch N, Noll E, et al. Use of transdermal nicotine in a state-level prescription plan for the elderly: a first look at “real world” patch users. JAMA. 1994;271:601–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Norusis MJ. SPSS: SPSS® for Windows™ Base System Release 6.0. Chicago:SPSS Inc., 1993.Google Scholar
  22. 22.
    Glynn T, Manley M. How to Help Your Patients Stop Smoking: A National Cancer Institute Manual for Physicians. Bethesda, MD:US DHHS; 1989. NIH Publication 89-3064.Google Scholar
  23. 23.
    Fiore MC, Jorenby DE, Baker TB. Kenford SL. Tobacco dependence and the nicotine patch: clinical guidelines for effective use. JAMA. 1992;268:2687–94.PubMedCrossRefGoogle Scholar
  24. 24.
    Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA. 1994;271:589–94.PubMedCrossRefGoogle Scholar
  25. 25.
    Centers for Disease Control. Reducing the Health Consequences of Smoking: 25 Years of Progress. Atlanta, GA:US DHHS; 1989. Publication DHHS(CDC)89-8411.Google Scholar
  26. 26.
    Hughes JR. Wadland WC, Fenwick JW, Lewis J. Bickel WK. Effect of cost on the self-administration and efficacy of nicotine gum: a preliminary study. Prev Med. 1991;20:486–96.PubMedCrossRefGoogle Scholar
  27. 27.
    Rothman KJ. Modern Epidemiology. Boston:Little, Brown, 1986;86–9.Google Scholar
  28. 28.
    Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12:159–82.PubMedCrossRefGoogle Scholar
  29. 29.
    Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983;51:390–5.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 1995

Authors and Affiliations

  • Susan H. Swartz
    • 1
  • Allan J. Ellsworth
    • 2
  • Susan J. Curry
    • 3
  • Edward J. Boyko
    • 1
  1. 1.the Medical ServiceVeteran Affairs Medical CenterSeattle
  2. 2.the Departments of Pharmacy and Family MedicineUniversity of WashingtonSeattle
  3. 3.the Center for Health StudiesGroup Health CooperativeSeattle

Personalised recommendations